Treatment of cancer with anti-IL-1alpha antibodies

Details for Australian Patent Application No. 2007252990 (hide)

Owner XBiotech Inc.

Inventors Simard, John

Agent Freehills

Pub. Number AU-B-2007252990

PCT Pub. Number WO2007/135546

Priority 60/802,166 22.05.06 US

Filing date 22 May 2007

Wipo publication date 29 November 2007

Acceptance publication date 27 October 2011

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/135546 Priority application(s): WO2007/135546

27 October 2011 Application Accepted

  Published as AU-B-2007252990

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007252991-Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis

2007252986-Progastrin inhibitors in the treatment of colon cancer